157 related articles for article (PubMed ID: 37494591)
21. Stereotactic Ablative Radiotherapy for stage I histologically proven non-small cell lung cancer: an Italian multicenter observational study.
Ricardi U; Frezza G; Filippi AR; Badellino S; Levis M; Navarria P; Salvi F; Marcenaro M; Trovò M; Guarneri A; Corvò R; Scorsetti M
Lung Cancer; 2014 Jun; 84(3):248-53. PubMed ID: 24681279
[TBL] [Abstract][Full Text] [Related]
22. Fractionated stereotactic radiotherapy of brain metastases: results of a retrospective study.
Gruber I; Stark P; Weidner K; Treutwein M; Koelbl O
Radiat Oncol; 2023 May; 18(1):85. PubMed ID: 37217924
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic Ablative Body Radiotherapy (SABR) in Pulmonary Oligometastatic/Oligorecurrent Non-small Cell Lung Cancer Patients: A New Therapeutic Approach.
Agolli L; Valeriani M; Nicosia L; Bracci S; De Sanctis V; Minniti G; Enrici RM; Osti MF
Anticancer Res; 2015 Nov; 35(11):6239-45. PubMed ID: 26504057
[TBL] [Abstract][Full Text] [Related]
24. Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent.
Buglione M; Jereczek-Fossa BA; Bonù ML; Franceschini D; Fodor A; Zanetti IB; Gerardi MA; Borghetti P; Tomasini D; Di Muzio NG; Oneta O; Scorsetti M; Franzese C; Romanelli P; Catalano G; Dell'Oca I; Beltramo G; Ivaldi GB; Laudati A; Magrini SM; Antognoni P;
Lung Cancer; 2020 Mar; 141():1-8. PubMed ID: 31926440
[TBL] [Abstract][Full Text] [Related]
25. A multi-institutional analysis of fractionated versus single-fraction stereotactic body radiotherapy (SBRT) in the treatment of primary lung tumors: a comparison between two antipodal fractionations.
Alongi F; Nicosia L; Figlia V; De Sanctis V; Mazzola R; Giaj-Levra N; Reverberi C; Valeriani M; Osti MF
Clin Transl Oncol; 2021 Oct; 23(10):2133-2140. PubMed ID: 33840047
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):386-394. PubMed ID: 34974972
[TBL] [Abstract][Full Text] [Related]
27. The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy.
Davis JN; Medbery C; Sharma S; Danish A; Mahadevan A
Radiat Oncol; 2013 Nov; 8():275. PubMed ID: 24274599
[TBL] [Abstract][Full Text] [Related]
28. Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT).
Reyngold M; Wu AJ; McLane A; Zhang Z; Hsu M; Stein NF; Zhou Y; Ho AY; Rosenzweig KE; Yorke ED; Rimner A
Radiat Oncol; 2013 Apr; 8():99. PubMed ID: 23617949
[TBL] [Abstract][Full Text] [Related]
29. Stereotactic body radiotherapy for centrally located early-stage non-small cell lung cancer or lung metastases from the RSSearch(®) patient registry.
Davis JN; Medbery C; Sharma S; Pablo J; Kimsey F; Perry D; Muacevic A; Mahadevan A
Radiat Oncol; 2015 May; 10():113. PubMed ID: 25975848
[TBL] [Abstract][Full Text] [Related]
30. A meta-analysis comparing stereotactic body radiotherapy vs conventional radiotherapy in inoperable stage I non-small cell lung cancer.
Li C; Wang L; Wu Q; Zhao J; Yi F; Xu J; Wei Y; Zhang W
Medicine (Baltimore); 2020 Aug; 99(34):e21715. PubMed ID: 32846789
[TBL] [Abstract][Full Text] [Related]
31. High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancer.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
J Gastrointest Oncol; 2022 Feb; 13(1):368-379. PubMed ID: 35284125
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic boost on residual disease after external-beam irradiation in clinical stage III non-small cell lung cancer: mature results of stereotactic body radiation therapy post radiation therapy (SBRTpostRT) study.
Parisi S; Ferini G; Lillo S; Brogna A; Chillari F; Ferrantelli G; Settineri N; Santacaterina A; Platania A; Leotta S; Casablanca G; Russo A; Pontoriero A; Adamo V; Minutoli F; Bottari A; Cacciola A; Pergolizzi S
Radiol Med; 2023 Jul; 128(7):877-885. PubMed ID: 37294366
[TBL] [Abstract][Full Text] [Related]
33. Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer.
Dubaere E; Goffaux M; Wanet M; Bihin B; Gheldof C; Demoulin AS; Bolly A; Bustin F; Duplaquet F; Baugnee PE; Gustin M; Hers V; Maisin F; Marchand E; Ocak S; Pirard L; Vancutsem O; Van Neck E; Vandermoten G; Zaharia L; Remouchamps V
BMC Cancer; 2019 Jun; 19(1):639. PubMed ID: 31253136
[TBL] [Abstract][Full Text] [Related]
34. Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer.
Chang JY; Liu YH; Zhu Z; Welsh JW; Gomez DR; Komaki R; Roth JA; Swisher SG
Cancer; 2013 Sep; 119(18):3402-10. PubMed ID: 23798353
[TBL] [Abstract][Full Text] [Related]
35. Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases.
Voglhuber T; Kessel KA; Oechsner M; Vogel MME; Gschwend JE; Combs SE
BMC Cancer; 2020 Jun; 20(1):536. PubMed ID: 32513136
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer.
Eriguchi T; Takeda A; Sanuki N; Tsurugai Y; Aoki Y; Oku Y; Hara Y; Akiba T; Shigematsu N
Lung Cancer; 2017 Jul; 109():62-67. PubMed ID: 28577952
[TBL] [Abstract][Full Text] [Related]
37. Impact of radiation dose to the immune system on disease progression and survival for early-stage non-small cell lung cancer treated with stereotactic body radiation therapy.
Wang X; Bai H; Gao M; Guan Y; Yu L; Li J; Dong Y; Song Y; Tao Z; Meng M; Wu Z; Zhao L; Yuan Z
Radiother Oncol; 2023 Sep; 186():109804. PubMed ID: 37437605
[TBL] [Abstract][Full Text] [Related]
38. Local control correlates with overall survival in radiotherapy for early-stage non-small cell lung cancer: A systematic review.
Sanuki N; Takeda A; Eriguchi T; Tsurugai Y; Tateishi Y; Kibe Y; Akiba T; Fukuzawa T; Horita N
Radiother Oncol; 2023 Jun; 183():109664. PubMed ID: 37024056
[TBL] [Abstract][Full Text] [Related]
39. Short-term outcomes and clinical efficacy of stereotactic body radiation therapy (SBRT) in treatment of adrenal gland metastases from lung cancer.
Zhao X; Zhu X; Fei J; Ren H; Cao Y; Ju X; Yuan Z; Zhang H
Radiat Oncol; 2018 Oct; 13(1):205. PubMed ID: 30348187
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy for synchronous early stage non-small cell lung cancer.
Steber CR; Hughes RT; Soike MH; Helis CA; Nieto K; Jacobson T; Nagatsuka M; McGinnis HS; Leyrer CM; Farris MK
Acta Oncol; 2021 May; 60(5):605-612. PubMed ID: 33645424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
